首页> 外文期刊>Expert opinion on therapeutic targets >Targeting c-FLICE-like inhibitory protein (CFLAR) in cancer
【24h】

Targeting c-FLICE-like inhibitory protein (CFLAR) in cancer

机译:在癌症中靶向c-FLICE样抑制蛋白(CFLAR)

获取原文
获取原文并翻译 | 示例
           

摘要

Introduction: Evasion of apoptosis (programmed cell death) is one of the characteristic hallmarks of human cancers and may be caused by aberrant expression of antiapoptotic proteins. Among those is c-FLICE-like inhibitory protein (c-FLIP), a protein that not only blocks apoptosis signaling but also regulates additional cell death pathways. Areas covered: Because c-FLIP is regulated both at the transcriptional and posttranscriptional level by various mechanisms and is a short-lived protein with a rapid turnover, the regulation of c-FLIP expression represents a versatile tool to modulate cell death signaling pathways. Because c-FLIP is aberrantly expressed in various cancers, it represents a promising target for therapeutic intervention. Expert opinion: Therefore, insights into the molecular events that regulate c-FLIP expression and activity in human cancers will provide the basis for the development of new strategies to target c-FLIP expression in human cancers.
机译:简介:规避凋亡(程序性细胞死亡)是人类癌症的特征之一,可能是由于抗凋亡蛋白的异常表达引起的。其中包括c-FLICE样抑制蛋白(c-FLIP),该蛋白不仅可以阻断细胞凋亡信号传导,而且还可以调节其他细胞死亡途径。涵盖的领域:由于c-FLIP受多种机制在转录和转录后水平调控,并且是具有快速更新的短命蛋白质,因此c-FLIP表达的调控代表了一种调节细胞死亡信号传导途径的多功能工具。由于c-FLIP在各种癌症中异常表达,因此它代表了治疗干预的有希望的靶标。专家意见:因此,对调节人类癌症中c-FLIP表达和活性的分子事件的深入了解将为开发针对人类癌症中c-FLIP表达的新策略提供基础。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号